EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of Fenfluramine on convulsive seizures and rescue medication usage: A case series of adults within the Lennox-Gastaut syndrome spectrum

Lisa Chilson, Boubker Zaaimi, Shanika Samarasekera

Epilepsy & Behavior Reports · 2026-12 · 36 · 100895

DOI: 10.1016/j.ebr.2026.100895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior Reports, 2026-12. Verfasst von Lisa Chilson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, United Kingdom. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adults with Developmental and epileptic encephalopathies (DEE) within the Lennox-Gastaut Syndrome (LGS) spectrum suffer disabling convulsive seizures which may remain refractory and are associated with increased risk of hospitalisations and death. Fenfluramine (FFA) was licenced in the UK for seizures associated with LGS in March 2025.

Methods

Adjunctive FFA was assessed in a series of 6 adults with a genetic DEE within the LGS spectrum treated for refractory convulsive seizures. The minimum period of observation was 9 months (range 9-32 months). 3 patients commenced FFA pre-licencing on compassionate grounds. 4 patients had a VNS, 5 patients were prescribed concomitant Cannabidiol. Reduction in convulsive seizures and reduction in use of rescue medications/ frequency of hospitalisations was also assessed. Caregiver responses were recorded using the Clinical Global Improvement of Change (CGI-I).

Results

At last follow up, all 6 patients remained on FFA. No significant side effects were observed. There was a significant reduction in seizures at last follow up (p = 0.035), with a corresponding reduction in use of rescue medications and hospitalisations. On the CGI-I, 5 of the 6 patients were rated as much/ very much improved, the remaining patient was rated as minimally improved.

Conclusion

Adjunctive FFA was tolerated without significant side effects and associated with a significant reduction in convulsive seizures in this limited cohort. Corresponding reduction in use of rescue medications and hospitalisations has the potential to impact on both patient and caregiver quality of life.

Schlagwörter

Stichwörter der Autor:innen

Lennox-gastaut spectrumepilepsyfenfluramine

Autor:innen und Institutionen

  • Department of Neurology, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, United Kingdom.
  • School of Life and Health Sciences, Aston University, Birmingham, UK.

Zitieren

APA

Chilson, L., Zaaimi, B., & Samarasekera, S. (2026). Effect of Fenfluramine on convulsive seizures and rescue medication usage: A case series of adults within the Lennox-Gastaut syndrome spectrum. Epilepsy & Behavior Reports, 36, 100895. https://doi.org/10.1016/j.ebr.2026.100895

Vancouver

Chilson L, Zaaimi B, Samarasekera S. Effect of Fenfluramine on convulsive seizures and rescue medication usage: A case series of adults within the Lennox-Gastaut syndrome spectrum. Epilepsy & Behavior Reports. 2026;36:100895. doi:10.1016/j.ebr.2026.100895

BibTeX
@article{Chilson2026,
  author = {Chilson, Lisa and Zaaimi, Boubker and Samarasekera, Shanika},
  title = {Effect of Fenfluramine on convulsive seizures and rescue medication usage: A case series of adults within the Lennox-Gastaut syndrome spectrum},
  journal = {Epilepsy & Behavior Reports},
  year = {2026},
  volume = {36},
  pages = {100895},
  doi = {10.1016/j.ebr.2026.100895}
}
Kostenlos starten →